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Abstract
Considerable advances have been made in the field of infant feeding research. The last few decades have witnessed
the expansion in the number of studies on the composition and benefits of human milk. The practice of breastfeeding
and use of human milk represent today’s reference standards for infant feeding and nutrition. Additional
research regarding the benefits of breastfeeding is needed to determine which factors in human milk and
in the act of breastfeeding itself, singly or in combination, are most important for producing the beneficial
effects on infant growth, body composition, and neurodevelopmental outcome. We examine evidence that
breastfeeding confers health benefits and offer suggestions on how best to interpret the data and present
it to the public. We also describe some examples of well-designed infant nutrition studies that provide useful
and clinically meaningful data regarding infant feeding, growth, and development. Because not all mothers
choose to breastfeed or can breastfeed, other appropriate feeding options should be subjected to critical
review to help establish how infant formula and bottle feeding can confer benefits similar to those of human
milk and the act of breastfeeding. We conclude with the overarching point that the goal of infant feeding
research is to promote optimal infant growth and development. Since parents/families may take different
paths to feeding their infants, it is fundamental that health professionals understand how best to interpret
research studies and their findings to support optimal infant growth and development.
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Introduction
In 2020, the U.S. Dietary Guidelines for Americans will
for the first time include recommendations for nutrition
of healthy infants and young children, as mandated by
the Agricultural Act of 2014 [1]. The review program
(B-24) that will eventually lead to the full integration of
nutritional needs of infants and children from birth to
24 months of age into future U.S. Dietary Guidelines has
been established [2]. This creates an unprecedented op-
portunity to give parents and family members practical
guidelines on how best to meet their children’s nutri-
tional needs during a critical time of growth and devel-
opment. It also brings to the fore the challenges of
developing science-based recommendations for nutrition
of infants and young children. As an anthropologist and
neonatologist, we provide the following commentary on
the unique history and complexities of infant nutrition
research. We examine the weight of evidence linking hu-
man milk and the act of breastfeeding to specific health
benefits, but also describe some of the inherent limita-
tions of infant feeding research involving both human
milk and infant formulas. Finally, we describe some
examples of recent well-designed infant nutrition studies
that provide useful and clinically meaningful data
regarding infant feeding, growth, and development.
Historical developments
Over a century ago, the proper feeding and care of in-
fants led to the development of infant nutrition research,
and to pediatrics as a medical specialty [3]. Among the
most important advances in infant feeding research was
the understanding of the composition of human milk
and the benefits that human milk and breastfeeding pro-
vide to the growing infant. The practice of breastfeeding
and use of human milk remain as the recommended and
reference standards for infant feeding and nutrition [4].
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In the last 50 years, the number of studies on the com-
position of human milk has increased, in part because of
research focused on making infant formulas more simi-
lar to human milk, particularly with respect to compos-
ition, nutritional value, tolerance, and performance [3].
Many of the early studies on infant feeding focused on
the role of different nutrients and their “metabolic bal-
ance” in normal infants, thus providing greater insight
into the requirements for optimal growth [5–8]. Now, we
know that body composition and neurodevelopmental
and physical function are just as important as weight gain
alone for determining optimal growth and development.
Today, a variety of infant formulas are available world-
wide. Infant formulas are available for preterm infants,
full-term infants, and toddlers as well as specialized
formulas for those infants and children with selected in-
born errors of metabolism. The compositions of these
formulas vary greatly depending on the nutritional needs
of the targeted infant population. The required essential
nutrients included in various infant formulas are pro-
vided in the global standards established by the Codex
Alimentarius Commission in 1981, and revised over the
years [9]. This standard also includes a list of food addi-
tives that are allowed to be added. Quality control mea-
sures such as labeling, packaging, contaminants and
hygiene are also specified. In the United States, stan-
dards for infant formula are the responsibility of the U.S.
Food and Drug Administration (FDA) [10]. The U.S.
Code of Federal Regulations Title 21, Part 106 specifies
infant formula quality control procedures and Part 107
lists the nutrient requirements and other rules concern-
ing labeling for infant formulas. Not surprisingly, the
quality and safety standards for infant formulas are
extremely high, exceeding most requirements for other
food products [10]. In the European Union, the legisla-
tion on the composition of infant formula and follow-on
formulas was adopted in 2006 and at the time of this
writing is being revised [11].
Complexities of infant nutrition research
The development of sophisticated analytical techniques
and ability to identify and investigate the effects of cer-
tain nutrients at a cellular level led to growth in the
number of known compounds in human milk. These
components include living cells, hormones, active en-
zymes, immunoglobulins, and a variety of bioactive com-
pounds and compounds with unique molecular structures
[12]. With this knowledge, it became increasingly appar-
ent that concentrations and types of nutrients in infant
formulas cannot always match exactly those in human
milk.
Studies have shown that some nutrients in human
milk, such as fat, protein, and the long-chain polyunsat-
urated omega-3 fatty acid (LCPUFA), docosahexaenoic
acid (DHA), vary from the beginning to the end of each
breastfeeding event, between the stages of lactation, and
as a result of different maternal diets [13]. The actual
contribution of these variations or many of the other
milk components to the nutrition provided by human
milk, however, has not been completely studied to deter-
mine their specific roles in affecting infant nutritional
outcomes. In contrast, new ingredients that are added to
infant formulas must be shown to be safe and provide
important clinical benefits based on extensive and care-
fully conducted clinical trials. Furthermore, even in clin-
ical practice, comparisons between human milk and
infant formula feeding are difficult to determine. Intake
volumes and exact composition and thus delivery of
nutrients from infant formula feeding can be known
quite precisely. In contrast, lack of clinically available
milk analyzers to measure even the gross nutrient com-
ponents in human milk (protein, in particular, but also
lipids and carbohydrates) and imprecise determination
of human milk feeding volume (weighing the infant
before and after each feeding is beyond the capacity of
most parents, except for short term and specific indica-
tions) limit assessment of what nutrition an infant actually
receives from human milk feeding. Thus, comparisons
between feeding outcomes of human milk and infant
formulas often have lacked a sufficiently common
research basis to determine whether infant formulas are
meeting the many unique, but incompletely understood
compositional benefits of human milk.
Recent research has demonstrated that infant nutrition
during critical windows in early development, both pre-
and postnatal, has the potential for producing lifelong
impacts on health and disease in childhood, adolescence,
and adult life [14–16]. The concept that the adequacy or
deficiency of a nutrient at a critical period of develop-
ment could influence or “program” a health or disease
outcome has important implications for individuals and
public health [16].
There has been an explosion of media attention on
infant feeding research. Even though popularization
of such studies through social media now is rampant,
many of the media reports do not represent easy to
understand explanations of results. Not uncommonly,
they also frequently lack rational scientific underpin-
nings (such as real data from randomized, controlled
investigations) and fail to clearly show how new
research has led to important new approaches to
nutrition, some of which are at odds with previous
recommendations. Thus, public health recommenda-
tions often are inconsistent and inadequately sup-
ported by scientific evidence, and in many cases may
be misunderstood by new parents. Most importantly,
parents often find it difficult to understand how
modern infant nutrition research applies to meeting
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the practical, day-to-day nutritional needs of their
growing infant. Similar confusion exists among health
professionals [17].
Problems with definitions of infant feeding and potential
self-reporting bias
One of the problems associated with infant feeding stud-
ies is that researchers use different definitions of breast-
feeding. For example, the “act of breastfeeding” typically
refers to the mother’s behavioral interaction with her
baby during feeding. Such behavioral interactions include
many types of contact (gentle to rough), temperature and
heat transfer, enface engagement, verbal communication,
and duration of contact, among others, as well as transfer
of mother’s microbiota. Behavioral interaction during
feeding also can involve other people—father, siblings,
other relatives, friends, all of whom can provide different
or additional effects on infant development that could
influence effects specific to milk or other foods. When
considering the actual food ingested by the infant, many
infant feeding studies use “breastfeeding” as the primary
analytical variable while other studies use “exclusive
breastfeeding” [4, 18]. The term “breastfeeding” includes
“infants fed human milk or a combination of human milk
and formula or cow’s milk”, and perhaps other foods too
[19]. “Exclusive breastfeeding”, on the other hand, typically
implies the feeding of human milk alone, although some
studies also include the feeding of other foods that are not
human milk substitutes. Thus, it is difficult to draw con-
clusions regarding the benefits of “exclusive breastfeed-
ing”, if that is the variable of interest, because the majority
of studies do not control for the confounding effects of
the additional non-human milk food items included in the
infants’ diet. Such limitations in defining degrees of
breastfeeding also fail to determine just how much breast-
feeding (or human milk feeding if donor milk is used)
actually produces defined outcomes.
Dietary surveys of infant feeding practices, especially
those conducted orally (e.g., by telephone), are often
affected by self-reporting bias, when participants tend to
under-report behaviors that are perceived to be inappro-
priate by researchers and over-report behaviors viewed
as appropriate [20]. The act of breastfeeding easily can
be placed in the category of a behavior perceived to be
“appropriate.” It seems likely that the practice of breast-
feeding obtained from a telephone survey may not be
accurately reported and as a result may confound the
results.
Infant feeding studies: problems related to study design
and weak associations
Infant feeding studies often focus on growth and devel-
opment, a specific disease, medical condition, or end-
point (e.g., IQ or vision) and can be separated into two
different categories: 1) those that show areas of research
that are promising and require more resources and time
to pursue, but do not provide conclusive evidence, and
2) those that provide more concrete evidence [21]. Con-
fusion arises when the results presented are preliminary
or are obtained from a subset of a few studies without a
balanced presentation of all the data [21]. The types of
studies that are commonly used to evaluate the effects of
food and/or food components on infant health and
growth and development are described in Table 1. These
types of studies also are used for a variety of other
purposes, including testing the efficacy and safety of
pharmaceutical products.
A problem with all nutrition and infant feeding studies
is that the list of possible influential factors is large when
each is not studied in isolation using rigorous, random-
ized experimental study designs, making it difficult to
evaluate both short- and long-term effects of any form
of infant feeding or nutritional substance used on any
one or group of outcomes [17].
The most obvious problem in neonatal nutrition is
that while the randomized clinical trial (RCT) is the
most scientific and rigorous method to evaluate the effi-
cacy of human milk feeding and the act of breastfeeding
on selected outcomes (neurodevelopment, body com-
position, etc.), it is impossible to conduct an RCT com-
paring human milk-fed vs. formula-fed infants, because
it is unethical to randomly assign infants to a breast-fed
or formula-fed treatment group. However, RCTs have
been promising in examining the effects of specific in-
gredients added to infant formula and/or human milk.
Often, a different human milk-fed group is used for
comparison as a control, although not all studies are
careful to select a different comparison group to be as
close to the study group as possible in all other factors
(e.g., see Ryan et al. [22] for a review of RCTs that con-
sidered the nutritional effects of LCPUFAs added to
infant formulas and human milk on neurological
development). Consequently, such infant feeding re-
search is vulnerable to many potential confounding
effects that are left unexamined, such as the different
definitions of infant feeding that are used among vari-
ous infant feeding studies or that different groups are
unique in other aspects that are not controlled. It
should be kept in mind, however, that the cost of
RCTs is typically very expensive. Sometimes, smaller,
proof-of-concept studies can initially address some
fundamental questions and provide evidence needed
to support additional RCTs.
Epidemiological/observational (E/O) studies seem to
draw most of the attention from both health profes-
sionals and the media. A number of nutritional claims
with “strong support” from E/O studies have in fact
shown conflicting results when the total body of
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evidence is considered [17, 23, 24]. As examples, some
observational follow-up studies indicated improved cog-
nitive and developmental outcomes in infants whose
mothers’ diets were supplemented with omega-3 LCPU-
FAs, particularly DHA, as the fetal brain accumulates
these LCPUFAs rapidly in the second half of pregnancy
[25–27], while other follow-up studies did not report
improved outcomes [28]. Even a systematic review
and meta-analysis of maternal LCPUFA supplementa-
tion could not conclusively refute or support supple-
mentation during pregnancy for improving cognitive
and visual outcomes of offspring [29]. However, a re-
cent consideration of childhood allergies indicated
some potential long-term benefits of LCPUFA supple-
mentation [30, 31].
Examples of promising infant feeding studies
There are many documented benefits to human milk
feeding and the act of breastfeeding (although the re-
search base varies widely in the strengths and weak-
nesses in study designs, controls, and findings), which
can include reduced rates of necrotizing enterocolitis
Table 1 Advantages and Limitations of Various Types of Nutrition Studies
Type of Study/Description Advantages Limitations
Cell culture – in vitro
Food item is placed in cells or other tissues
in culture conditions.
Help determine mechanisms of action.
Provide clues for further investigation to
define mechanisms responsible for how
food components interact with host cells.
What occurs in cells may be different
from what occurs in human body.
Not conclusive.
Animal – in vivo
Food item is fed to laboratory animals (e.g. rat,
mouse, guinea pig, rabbit). Tests the effects of
food on certain diseases, physiological conditions,
and behaviors
Can be tightly controlled for testing the
metabolism, specificity, and reproducibility
of the effect of a certain food component.
Tests the toxicity and safety of food
components added to the diet.
Humans differ from animals in many
aspects of their physiology, such as food




One individual’s experience with food or a food
component is documented.
Help determine how certain food/
components may affect clinical conditions
or disorders in humans.
Focus on social, psychological, or medical conditions.
Provide clues for further investigation.
Not scientifically rigorous – only one
person’s experience.
Not conclusive but is more evidence-
building.
Epidemiological/observational
Groups of subjects, typically living in one
geographical area, who have developed a
disease or condition are compared with a
similar sample of subjects who have not
developed the disease.
Address whether a certain food/component
could cause a disease but not whether it
did cause a disease.
Memory recall is often used to assess
how a food/component might have
affected an individual – long-term
memory recall may not be accurate.
Regionally biased – differences observed
between regions may be related to
different dietary of cultural preferences
or genetic differences.
Not conclusive but is more evidence-
building.
Prospective cohort studies
A large group of individuals with a similar
background who are healthy when the study
begins are followed over time. Diets are assessed
at the beginning, during, and end of the study.
Eating habits of those who get a disease are
compared to those who do not acquire a disease.
Provide clues about the risk/benefits of a
given diet, food component or lack of an
important vitamin/mineral (e.g., development
of iron deficiency and neurodevelopmental
impairment) over time.
The controls may not be similar to
those who acquire a disease with
respect to demographic and health
factors.
Not conclusive but is more evidence-
building.
Randomized, controlled clinical trial (RCT)
Evaluates the efficacy of a specific nutritional
intervention (e.g., food/component) within a
population. Subjects with similar backgrounds
are randomly allocated to receive either the test
item or placebo.
Represents the “gold standard” for clinical
trial methodology.
Randomization minimizes allocation bias
by balancing both known and unknown
social and health factors.
Sample sizes are often large to detect
subtle differences in treatments, diet or
food component when they exist.
Provides most conclusive evidence.
Unethical to randomize breastfed
infants into an infant formula feeding
group.
Meta-analysis
Review of the existing scientific literature.
Pooled data from several studies are subjected
to a statistical meta-analysis.
Meta-analysis of trials provides a more
precise estimate of the treatment effect
because of the increased sample size and
statistical power.
Results can be generalized to a larger
population.
Inconsistency of results across studies can
be quantified and analyzed.
The validity of the meta-analysis
depends on the quality of the
systematic review and studies
included in the analysis.
If confounding variables are
not controlled for in the primary
studies, there will be potential
bias in the meta-analysis (e.g.,
differing definitions of breastfeeding).
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(NEC), respiratory infections and otitis media, sudden
infant death syndrome, gastrointestinal infections, atopic
diseases, celiac disease, inflammatory bowel disease,
diabetes mellitus, leukemia, obesity, and improved neu-
rodevelopmental outcomes, particularly in relation to
the duration of breastfeeding [4]. In some cases, it is rea-
sonably clear that such benefits are specific to the milk
itself, for example, with reduced rates of NEC, since pre-
term infants who develop NEC are fed by gavage and
not from the breast.
Optimal nutritional management of NEC is of great
interest because NEC is the most common and danger-
ous gastrointestinal medical emergency in premature
infants [32]. The type of infant feeding and its relation-
ship to the development of NEC has been the subject of
several clinical trials [33–36]. In a large prospective trial
(an RCT cannot not be performed in this sensitive popu-
lation as discussed above), human milk-fed infants devel-
oped NEC 6 to 10 times less often than those fed infant
formula exclusively and 3 times less often if they were
fed a mixture of human milk and infant formula [36].
Systematic reviews of RCTs have indicated that pro-
biotics added to infant formula and/or human milk may
reduce the incidence of mortality from NEC and the
development of late onset sepsis [37, 38], as well as
reducing the time to full enteral feedings that resulted in
better weight gain and growth [39]. Probiotics also have
been suggested to improve the quality of intestinal
mucus, increase gut motility, and limit the production of
inflammatory cytokines [33, 39]. Most of the RCTs used
combinations of different strains of Bifidobacterium
added to infant formula or human milk, making it diffi-
cult to determine which of the many different probiotic
organisms is most beneficial. Clinical trials are ongoing
to determine the most effective preparation of probiotics
[40]. The most recent trial in the UK (PiPS Study, or
Probiotics in Preterm Infants Study) did not show a
benefit to reducing NEC, although it used only one pro-
biotic organism (Bifidobacterium breve) [41]. Whether
probiotics actually do reduce the rates of NEC and/or late
on sepsis remains highly controversial [42], with clinical
practice widely variable, even for the use of some of the
probiotic organisms that have shown promise [43].
Additional research is needed to identify those attributes
of human milk and those related to the act of breastfeed-
ing that underlie improved outcomes. It remains unclear,
for example, what it is in human milk that reduces the risk
of NEC. It might be nutrient components of milk (DHA,
for example, or immunoglobulins, lactoferrin, lysozyme,
and various immunonutrients) [44], or it might be the
microbiome that comes from the milk or independently
from the mother and not the human milk itself [45, 46].
Some human milk oligosaccharides (HMOs) also
might have a protective role in preterm infants by
decreasing pathogens associated with sepsis and NEC,
but other HMOs can increase the composition of abnor-
mal and potentially pathogenic organisms among the
intestinal microbiota [47]. There are considerable differ-
ences among the HMOs in the milk of mothers of just
born preterm infants than later after birth or from term
infants or from mature donor milk [48, 49]. HMOs
appear to have at least two positive functions: they pro-
duce prebiotic activity by stimulating the growth of com-
mensal bacteria in the gut and they provide protection
against pathogens [48, 50]. Oligosaccharides are also as-
sociated with infant growth and body composition [51].
Studies have suggested that certain growth factors (e.g.,
epidermal growth factor, a compound found in human
milk and not in infant formula) may reduce the risk of
NEC by limiting the damage caused by bile acids [52].
Determining such factors is essential to help modify
infant formulas to provide the same protective benefits
as human milk, since many preterm infants are fed
infant formulas, and also because what initially might ap-
pear beneficial, on more detailed analysis, could include
some adverse components.
Equally compelling would be the consideration of the
specific role of the microbiome that is produced from
human milk (preterm, term, or donor human milk),
infant formulas, and the act of breastfeeding, since inter-
action of microbes and the human host mucosal im-
mune system likely play major roles in diseases seen in
the neonatal intensive care unit such as NEC and late
onset sepsis. This interaction also likely relates to subse-
quent health in terms of susceptibility to allergic and
autoimmune diseases and the metabolic syndrome. An-
other area of research for human milk, infant formulas,
and the act of breastfeeding is to determine what consti-
tutes a “normal” intestinal microbiome in the infant,
regardless of gestational age at birth or postnatal age.
The influence of behavioral factors that affect the micro-
biome and its functions other than human milk or infant
formula and their components may be just as important,
particularly for those infants exposed to antibiotics,
either ante-or postpartum [53].
It also is fundamental to identify those attributes of
the act of breastfeeding that could be important for opti-
mal nutrition of infants and for reducing adverse out-
comes as well as improving neurodevelopment. Could
skin-to-skin contact even without breastfeeding or hu-
man milk feeding be helpful in establishing a healthy
microbiome in the infant based on the mother’s micro-
biome? How might the way the breast-fed infant is held,
how often, and for how long at each holding provide im-
portant clues for how a mother might adapt her bottle-
feeding techniques to more closely mimic what might be
beneficial in the breast-fed infant? Could holding and
feeding by the father or siblings or other caretakers
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provide the same benefits for the bottle-fed infant that
might be important for outcomes noted among breast-
fed infants? Such questions and others should be ad-
dressed, not just to help parents improve feeding skills,
but also to determine what is beneficial to breastfeeding
specifically, since many human milk fed infants are fed
expressed milk by bottle. Such outcomes also might
benefit those infants fed infant formulas by bottle.
New infant formulas continue to be tested in an at-
tempt to achieve similar benefits provided by human
milk. For example, to prevent and treat atopic diseases
and allergies during infancy, partially hydrolyzed infant
formulas are becoming increasingly used worldwide
[54]. A review of the literature to determine whether
these infant formulas may be recommended for feeding
all infants, if breastfeeding is not possible, revealed that
adverse effects on health were not apparent, but data
about potential benefit or risk of specific long-term out-
comes, particularly those referring to immune, metabolic
and hormonal effects, were nonexistant [54].
Recommendations and conclusions
When public health recommendations regarding infant
feeding (both breastfeeding and infant formula feeding)
are disseminated, scientists and public health officials
must put the strengths and limitations of the existing
research into proper perspective. There needs to be a
commitment to faithful reporting, a balance of data
presentation, and a description of evidence in non-
misleading ways [55]. New study design techniques, such
as sibling-pair comparisons in which one sibling is
breast-fed while another is not, are being used that may
help account for the selection bias that typically hinders
efforts to measure more precisely the effects of any one
or mixed type of infant feeding [56, 57]. Even this sort of
study design, however, does not control for why a
mother would chose to feed two infants differently. To
help distinguish the act of feeding from its use to pro-
vide food, other studies should investigate the effects of
administering human milk vs. infant formulas through
gavage tubes or via bottles on infant development [14],
particularly in preterm infants in the neonatal intensive
care unit, where the qualities of what is fed through gav-
age tubes or by bottles are separated from those of the
mother providing human milk by breastfeeding (includ-
ing specifically the use of donor milk, which is pooled
from many women of different backgrounds and condi-
tions and environments). Specific ingredients also have
been added to infant formulas and human milk to meas-
ure their effects on a variety of outcomes [58]. The im-
pact of variation in human milk composition also needs
to be further explored. Unfortunately in the U.S., the
FDA has not yet licensed milk analyzers for clinical use,
making it difficult to know what an infant who is fed
milk, of any kind, actually receives in terms of nutrient
components and thus how to optimize nutrition of an
infant who might need more or less of any one compo-
nent of milk.
Providing human milk (as a food) cannot be easily dis-
tinguished from the act of breastfeeding any more than
infant formula and table food feeding can be considered
separately from the behavior of those doing the feeding
and the many environmental conditions that are in-
volved in feeding infants. The act of breastfeeding may
represent an orientation toward a parenting style that in
itself has some positive intrinsic value relative to health
[17]. Conscientious feeding of infant formulas and table
foods also can have specific benefits.
The goal of infant feeding research, above all, is to
promote optimal infant growth, body composition, and
development. In evaluating the scientific evidence base
for developing infant and young child nutrition recom-
mendations, it is important to consider the many inher-
ent limitations of various methodologies and study
designs. Feeding recommendations need to be inform-
ative, yet practical, and balanced to help address the real
world decisions today’s diverse families and caregivers
must make when it comes to feeding infants and young
children.
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